Patent · US Active

Methods and pharmaceutical compositions for treatment of retinal occlusion

US9463217B1 · kind B1 · utility

1Cited by
0References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 8, 2013
Grant dateOct 11, 2016
Priority date
Expiry dateFeb 6, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to methods and compositions for the treatment of retinal vein occlusion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.